In the talks both ourselves and NHS England continued to offer as much flexibility as possible, but despite the intervention of Secretary of State for Health Wes Streeting, the companies did not put ...

These tools set cookies that store anonymised information about how you got to the site, and how you interact with the site.

Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux disease Interventional procedure consultation Interventional procedures guidance 12 December 2024 Zilucoplan for treating ...

Two technologies that could reduce the severity of the symptoms of chronic tic disorders and Tourette syndrome have been recommended for use in draft guidance from NICE. It is the first time a NICE ...

Guidance that can help you make cost savings and find efficiencies in your local services. Includes impact reports and templates that allow you to accurately estimate savings for your local setting. A ...

Our processes and methods manual describes how we estimate the resource impact of NICE guidance. This ensures the assessments meet users' needs. The manual covers: NICE guidelines technology ...

Quizartinib for induction, consolidation and maintenance treatment of newly diagnosed FLT3-ITD-positive acute myeloid leukaemia TA1013 23 October 2024 23 October 2024 ...

According to the study, technologies that received scientific advice took a median of 312 days to progress from marketing authorisation to NICE guidance publication. In contrast, those without such ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

There is a simple discount patient access scheme for elafibranor. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...